Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.42 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22749156 | 0.98 | TP53 (0.47) | TP53GPR84FFAR1SMPD1FFAR4 | |
| SCHEMBL211159 | 0.90 | TP53 (0.41) | TP53GPR84FFAR1FDPS | |
| SCHEMBL22749155 | 0.84 | GPR84 (0.45) | TP53GPR84FFAR1SMPD1FFAR4 | |
| SCHEMBL710698 | 0.81 | TP53 (0.34) | TP53FDPS | |
| SCHEMBL28024538 | 0.81 | TP53 (0.46) | TP53GPR84FFAR1SMPD1FDPS | |
| SCHEMBL24091301 | 0.80 | TP53 (0.48) | TP53GPR84FFAR1SMPD1FDPS | |
| SCHEMBL11694790 | 0.80 | TP53 (0.48) | TP53GPR84FFAR1SMPD1FDPS | |
| SCHEMBL6686083 | 0.80 | TP53 (0.48) | TP53GPR84FFAR1SMPD1FDPS | |
| SCHEMBL1931553 | 0.80 | TP53 (0.48) | TP53GPR84FFAR1SMPD1FDPS | |
| SCHEMBL6480248 | 0.80 | TP53 (0.48) | TP53GPR84FFAR1SMPD1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080206355-A1 | Composition comprising a particulate zinc material, a pyrithione or a polyvalent metal salt of a pyrithione and a synthetic cationic polymer | THE PROCTER & GAMBLE COMPANY | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080206355-A1 | Composition comprising a particulate zinc material, a pyrithione or a polyvalent metal salt of a pyrithione and a synthetic cationic polymer | SLC39A3, SLC39A14, SLC30A7 | TP53 267/4885GPR84 1790/4885FFAR1 1811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.